Ken-ichiro Kataoka

Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin

Takami Tomiyama, Akira Shoji, Ken-ichiro Kataoka et al. · Journal of Biological Chemistry · 1996 · 292 citations · Full text

Life Sciences, Neuroscience, Pharmacology +15

Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction

Takami Tomiyama, Hideshi Kaneko, Ken-ichiro Kataoka et al. · Biochemical Journal · 1997 · 90 citations · Full text

Medicine, Biochemistry, Pharmacology +15

Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo[1,5-<i>a</i>]pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach

T. Kosugi, Dale R. Mitchell, Aiko Fujino et al. · Journal of Medicinal Chemistry · 2012 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure–activity relationships of diamine derivatives

Wilna J. Moree, Ken-ichiro Kataoka, Michele M. Ramirez‐Weinhouse et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Acid-catalyzed amino-migration of O-phenylhydroxylamines

Naoki Haga, Yasuyuki Endo, Ken-ichiro Kataoka et al. · Journal of the American Chemical Society · 1992 · 39 citations

Natural Sciences, Biochemistry, Chemistry +6